BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10631118)

  • 21. The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.
    Williams SJ; Munster DJ; Quin RJ; Gotley DC; McGuckin MA
    Biochem Biophys Res Commun; 1999 Jul; 261(1):83-9. PubMed ID: 10405327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
    Yamada SM; Bruner JM; Berger MS; Morrison RS
    No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
    Abbass SA; Asa SL; Ezzat S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1160-6. PubMed ID: 9100589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
    Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
    Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Tgif2 gene contains a retained intron within the coding sequence.
    Melhuish TA; Wotton D
    BMC Mol Biol; 2006 Jan; 7():2. PubMed ID: 16436215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient use of a 'dead-end' GA 5' splice site in the human fibroblast growth factor receptor genes.
    Brackenridge S; Wilkie AO; Screaton GR
    EMBO J; 2003 Apr; 22(7):1620-31. PubMed ID: 12660168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
    Kwabi-Addo B; Ropiquet F; Giri D; Ittmann M
    Prostate; 2001 Feb; 46(2):163-72. PubMed ID: 11170144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer.
    Jang JH; Shin KH; Park YJ; Lee RJ; McKeehan WL; Park JG
    Cancer Res; 2000 Aug; 60(15):4049-52. PubMed ID: 10945607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates.
    Story MT; Hopp KA; Molter M; Meier DA
    Growth Factors; 1994; 10(4):269-80. PubMed ID: 7528517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse.
    Wuechner C; Nordqvist AC; Winterpacht A; Zabel B; Schalling M
    Int J Dev Biol; 1996 Dec; 40(6):1185-8. PubMed ID: 9032024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor.
    Grosse R; Schöneberg T; Schultz G; Gudermann T
    Mol Endocrinol; 1997 Aug; 11(9):1305-18. PubMed ID: 9259321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific.
    Scotet E; Houssaint E
    Biochim Biophys Acta; 1995 Nov; 1264(2):238-42. PubMed ID: 7495869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer.
    Leung HY; Gullick WJ; Lemoine NR
    Int J Cancer; 1994 Dec; 59(5):667-75. PubMed ID: 7960240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor receptor-4 splice variants cause deletion of a critical tyrosine.
    van Heumen WR; Claxton C; Pickles JO
    IUBMB Life; 1999 Jul; 48(1):73-8. PubMed ID: 10791918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors.
    Sanchez C; Escrieut C; Clerc P; Gigoux V; Waser B; Reubi JC; Fourmy D
    Mol Cell Endocrinol; 2012 Feb; 349(2):170-9. PubMed ID: 22040601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.
    Yamaguchi F; Saya H; Bruner JM; Morrison RS
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):484-8. PubMed ID: 8290551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of a fibroblast growth factor receptor 1 splice variant from Xenopus embryos that lacks a protein kinase C site important for the regulation of receptor activity.
    Gillespie LL; Chen G; Paterno GD
    J Biol Chem; 1995 Sep; 270(39):22758-63. PubMed ID: 7559402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue.
    Egerod KL; Holst B; Petersen PS; Hansen JB; Mulder J; Hökfelt T; Schwartz TW
    Mol Endocrinol; 2007 Jul; 21(7):1685-98. PubMed ID: 17488974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.
    Sturla LM; Merrick AE; Burchill SA
    Br J Cancer; 2003 Oct; 89(7):1276-84. PubMed ID: 14520460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exon skipping causes alteration of the COOH-terminus and deletion of the phospholipase C gamma 1 interaction site in the FGF receptor 2 kinase in normal prostate epithelial cells.
    Yan G; McBride G; McKeehan WL
    Biochem Biophys Res Commun; 1993 Jul; 194(1):512-8. PubMed ID: 8333865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.